Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

• 主要な著者: Sharon Baum (著者), Tal Raviv (著者), Sarit Gilboa (著者), Felix Pavlotsky (著者), Aviv Barzilai (著者)
• フォーマット: 図書
• 出版事項: Medical Journals Sweden, 2020-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established. This study aimed to evaluate the effect of repeated rituximab courses on remission length in pemphigus vulgaris. A...